Influence of statins treatment on survival in patients with amyotrophic lateral sclerosis

Journal of the Neurological Sciences

Volumn 273, Issue 1-2, 2008, Pages 81-83

  Drory, Vivian E ^a   Bronipolsky, Tatiana ^a   Artamonov, Irena ^a   Nefussy, Beatrice ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Amyotrophic lateral sclerosis; Dyslipidemia; Lipid lowering drugs; Motor neuron disease; Statins

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; RILUZOLE; SIMVASTATIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 50049086630     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.06.022     Document Type: Article

References (14)

1. Thavendiranathan P., Bagai A., Brookhart M.A., and Choudry N.K. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med 166 (2006) 2307-2313
2. Armitage J. The safety of statins in clinical practice. Lancet 370 (2007) 1781-1790
3. Harper C.R., and Jacobson T.A. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Curr Opin Lipidol 18 (2007) 401-408
4. Ahn S.C. Neuromuscular complications of statins. Phys Med Rehabil Clin N Am 19 (2008) 47-59
5. Chong P.H., Boskovich A., Stevkovic N., and Bartt R.E. Statin-associated peripheral neuropathy: review of the literature. Pharmacotherapy 24 (2004) 1194-1203
6. Purvin V., Kawasaki A., Smith K.H., and Kesler A. Statin-associated myasthenia gravis: report of 4 cases and review of the literature. Medicine (Baltimore) 85 (2006) 82-85
7. Edwards I.R., Star K., and Kiuru A. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase. Drug Saf 30 (2007) 515-525
8. Brooks B.R., Miller R.G., Swash M., and Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotr Later Scler 1 (2000) 293-299
9. Zoccolella S., Beghi E., Palagano G., et al. Predictors of long survival in amyotrophic lateral sclerosis: a population based study. J Neurol Sci 268 (2008) 28-32
10. Arvanitakis Z., Schneider J.A., Wilson R.S., et al. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology 70 (2008) 1795-1802
11. Li G., Larson E.B., Sonnen J.A., et al. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology 69 (2007) 878-885
12. Wolozin B., Wang S.W., Li N.C., Lee A., Lee T.A., and Kazis L.E. Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Medicine 5 (2007) 20-30
13. Wahner A.D., Bronstein J.M., Bordelon Y.M., and Ritz B. Statin use and the risk of Parkinson's disease. Neurology 70 (2008) 1418-1422
14. Dupuis L., Corcia P., Fergani A., et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology 70 (2008) 1004-1009